Precigen
PGEN
$1.41
Share price
0.71%
Change (1 day)
16.53%
Change (1 year)
Categories
Precigen (PGEN) - Total debt
Total debt on the balance sheet as of December 2023 : $7.09 M
According to Precigen's latest financial reports the company's total debt is $7.09 M. A company’s total debt is the sum of all current and non-current debts.
Precigen - Total debt on balance sheet (from 2012 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $51.42 M | -72.95% |
| 2021-12-31 | $0.19 B | 4.27% |
| 2020-12-31 | $0.18 B | -21.65% |
| 2019-12-31 | $0.23 B | 9.66% |
| 2018-12-31 | $0.21 B | 2465.43% |
| 2017-12-31 | $8.27 M | -5.68% |
| 2016-12-31 | $8.76 M | -3.53% |
| 2015-12-31 | $9.08 M | -28.1% |
| 2014-12-31 | $12.64 M | 664.79% |
| 2013-12-31 | $1.65 M | 1716.48% |
| 2012-12-31 | $0.09 M | -45.83% |
| 2011-12-31 | $0.16 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $1.5 M | -78.85% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $47.82 M | 573.81% | 🇬🇧 UK |
 Novavax NVAX | $0.22 B | 3,127.86% | 🇺🇸 USA |
 Novocure
NVCR | $0.59 B | 8,301.32% | Jersey |